World J Mens Health.  2016 Aug;34(2):137-144. 10.5534/wjmh.2016.34.2.137.

Development of an Improved Animal Model of Overactive Bladder: Transperineal Ligation versus Transperitoneal Ligation in Male Rats

Affiliations
  • 1Department of Urology, College of Medicine, The Catholic University of Korea, Seoul, Korea. ksw1227@catholic.ac.kr
  • 2Catholic Integrative Medicine Research Institute, The Catholic University of Korea, Seoul, Korea.
  • 3Korea Bio Medical Science Institute, Seoul, Korea.

Abstract

PURPOSE
We compared a transperineal ligation model and a transperitoneal ligation model in male rats to determine which animal model of overactive bladder (OAB) was more useful based on cystometrography, estimations of oxidative stress, and measurements of pro-inflammatory cytokine levels.
MATERIALS AND METHODS
Male rats were randomly divided into three groups (n=15 in each): the control group, the transperineal ligation group, and the transperitoneal ligation group. Four weeks after the ligation procedure, cystometrography was performed and oxidative stress, pro-inflammatory cytokine levels, and histologic changes were evaluated. Oxidative stress was assessed by measuring 8-hydroxy-20-deoxyguanosine and superoxide dismutase, and pro-inflammatory cytokine activity was investigated by measuring levels of interleukin (IL)-6, IL-8, and tumor necrosis factor-α.
RESULTS
The transperineal model led to results similar to those observed for the transperitoneal model, namely (1) increased voiding frequency and reductions in the non-voiding contraction interval and the maximal vesical pressure, (2) increased levels of oxidative stress markers, (3) increased pro-inflammatory cytokine levels, and (4) fibrotic changes in the bladder tissue.
CONCLUSIONS
We suggest that the transperineal procedure can be used as an alternative OAB model in male rats.

Keyword

Rats; Urinary bladder, overactive; Urinary bladder neck obstruction

MeSH Terms

Animals*
Humans
Interleukin-8
Interleukins
Ligation*
Male*
Models, Animal*
Necrosis
Oxidative Stress
Rats*
Superoxide Dismutase
Urinary Bladder
Urinary Bladder Neck Obstruction
Urinary Bladder, Overactive*
Interleukin-8
Interleukins
Superoxide Dismutase

Figure

  • Fig. 1 Surgical procedure for the transperineal model. (A) Catheterization of a polyethylene tube through the urethral orifice. (B) A needle with a 3-0 silk suture was used to make a suture penetrating around the perineal urethra. (C) A knot was made smoothly in the presence of the tube. (D) Unnecessary thread was removed. (E) The polyethylene tube was removed.

  • Fig. 2 Representative cystometrography tracings showing the changes in voiding function in the control group (n=15), the transperineal group (n=13), and the transperitoneal group (n=11).

  • Fig. 3 Comparison of oxidative stress in bladder tissue from the control group (n=15), the transperineal group (n=13), and the transperitoneal group (n=11). 8-OHdG: 8-hydroxy-2-deoxyguanosine, SOD: superoxide dismutase. *p< 0.05.

  • Fig. 4 Comparison of cytokine levels in bladder tissue from the control group (n=15), the transperineal group (n=13), and the transperitoneal group (n=11). IL: interleukin, TNF: tumor necrosis factor. *p<0.05.

  • Fig. 5 Comparison of histologic findings of representative sections of bladder tissue stained with H&E (×200). (A) The control group (n= 15). (B) The transperineal group (n=13). (C) The transperitoneal group (n=11). (D) Ratio of smooth muscle to collagen in the bladder. *p< 0.05.


Reference

1. Sarma AV, Wei JT, Jacobson DJ, Dunn RL, Roberts RO, Girman CJ, et al. Comparison of lower urinary tract symptom severity and associated bother between communitydwelling black and white men: the olmsted county study of urinary symptoms and health status and the flint men's health study. Urology. 2003; 61:1086–1091. PMID: 12809866.
Article
2. Verhamme KM, Dieleman JP, Bleumink GS, van der Lei J, Sturkenboom MC, Artibani W, et al. Incidence and prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in primary care: the triumph project. Eur Urol. 2002; 42:323–328. PMID: 12361895.
3. Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol. 1984; 132:474–479. PMID: 6206240.
Article
4. Peters TJ, Donovan JL, Kay HE, Abrams P, de la Rosette JJ, Porru D, et al. The international continence society "Benign Prostatic Hyperplasia" study: the botherosomeness of urinary symptoms. J Urol. 1997; 157:885–889. PMID: 9072592.
5. Eckhardt MD, van Venrooij GE, van Melick HH, Boon TA. Prevalence and bothersomeness of lower urinary tract symptoms in benign prostatic hyperplasia and their impact on well-being. J Urol. 2001; 166:563–568. PMID: 11458069.
Article
6. Dmochowski RR, Staskin D. Overactive bladder in men: special considerations for evaluation and management. Urology. 2002; 60:56–62. PMID: 12493356.
Article
7. Roosen A, Chapple CR, Dmochowski RR, Fowler CJ, Gratzke C, Roehrborn CG, et al. A refocus on the bladder as the originator of storage lower urinary tract symptoms: a systematic review of the latest literature. Eur Urol. 2009; 56:810–819. PMID: 19683859.
Article
8. de Nunzio C, Franco G, Rocchegiani A, Iori F, Leonardo C, Laurenti C. The evolution of detrusor overactivity after watchful waiting, medical therapy and surgery in patients with bladder outlet obstruction. J Urol. 2003; 169:535–539. PMID: 12544303.
Article
9. Fox C, Smith T, Maidment I, Chan WY, Bua N, Myint PK, et al. Effect of medications with anti-cholinergic properties on cognitive function, delirium, physical function and mortality: a systematic review. Age Ageing. 2014; 43:604–615. PMID: 25038833.
10. Gillespie JI. A developing view of the origins of urgency: the importance of animal models. BJU Int. 2005; 96(Suppl 1):22–28. PMID: 16086676.
Article
11. Wróbel A, Łańcut M, Rechberger T. A new model of detrusor overactivity in conscious rats induced by retinyl acetate instillation. J Pharmacol Toxicol Methods. 2015; 74:7–16. PMID: 25957030.
Article
12. Juszczak K, Ziomber A, Wyczolkowski M, Thor PJ. Urodynamic effects of the bladder C-fiber afferent activity modulation in chronic model of overactive bladder in rats. J Physiol Pharmacol. 2009; 60:85–91. PMID: 20065501.
13. Takeda H, Yamazaki Y, Igawa Y, Kaidoh K, Akahane S, Miyata H, et al. Effects of beta(3)-adrenoceptor stimulation on prostaglandin E(2)-induced bladder hyperactivity and on the cardiovascular system in conscious rats. Neurourol Urodyn. 2002; 21:558–565. PMID: 12382247.
14. Okutsu H, Matsumoto S, Ohtake A, Suzuki M, Sato S, Sasamata M, et al. Effect of tamsulosin on bladder blood flow and bladder function in a rat model of bladder over distention/emptying induced bladder overactivity. J Urol. 2011; 186:2470–2477. PMID: 22019173.
Article
15. Drake M, Gillespie J, Hedlund P, Harvey I, Lagou M, Andersson KE. Muscarinic stimulation of the rat isolated whole bladder: pathophysiological models of detrusor overactivity. Auton Autacoid Pharmacol. 2006; 26:261–266. PMID: 16879491.
Article
16. Kato K, Wein AJ, Kitada S, Haugaard N, Levin RM. The functional effect of mild outlet obstruction on the rabbit urinary bladder. J Urol. 1988; 140:880–884. PMID: 3418826.
Article
17. Wolffenbuttel KP, Kok DJ, Minekus JP, van Koeveringe GA, van Mastrigt R, Nijman JM. Urodynamic follow-up of experimental urethral obstruction in individual guinea pigs. Neurourol Urodyn. 2001; 20:699–713. PMID: 11746551.
Article
18. Mattiasson A, Uvelius B. Changes in contractile properties in hypertrophic rat urinary bladder. J Urol. 1982; 128:1340–1342. PMID: 7154206.
Article
19. Zhang NZ, Ma L, Zhang JB, Chen J. Improved model for the establishment and evaluation of detrusor overactivity in female Wistar rats. Int Braz J Urol. 2014; 40:414–421. discussion 422. PMID: 25010309.
Article
20. Bae WJ, Ha US, Kim KS, Kim SJ, Cho HJ, Hong SH, et al. Effects of KH-204 on the expression of heat shock protein 70 and germ cell apoptosis in infertility rat models. BMC Complement Altern Med. 2014; 14:367. PMID: 25269420.
Article
21. Yoon BI, Bae WJ, Kim SJ, Kim HS, Ha US, Sohn DW, et al. The anti-inflammatory effects of a new herbal formula (WSY-1075) in a nonbacterial prostatitis rat model. World J Mens Health. 2013; 31:150–156. PMID: 24044110.
Article
22. Bae WJ, Ha US, Choi JB, Kim KS, Kim SJ, Cho HJ, et al. Protective effects of KH-204 in the bladder of androgen-deprived rats. World J Mens Health. 2015; 33:73–80. PMID: 26331123.
Article
23. Oka M, Fukui T, Ueda M, Tagaya M, Oyama T, Tanaka M. Suppression of bladder oxidative stress and inflammation by a phytotherapeutic agent in a rat model of partial bladder outlet obstruction. J Urol. 2009; 182:382–390. PMID: 19447421.
Article
Full Text Links
  • WJMH
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr